Meningitis Diagnostic Testing Market Size and Outlook Report 2024-2031

Meningitis Diagnostic Testing Market Size, Share, Industry, Forecast and Outlook (2024-2031)

<h2>Global Meningitis Diagnostic Testing Market&nbsp;Size, Share &amp; Trends Analysis Report By Infection Type, Diagnosis Type, By End-user, By Region, And Segment Forecasts, 2024 &ndash; 2031</h2>

<h3>Market Overview</h3>

<blockquote>
<p>Global Meningitis Diagnostic Testing Market reached US$ YY&nbsp;million in 2023 and is expected to reach US$ YY&nbsp;million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031</p>
</blockquote>

<p>Meningitis is an infection and inflammation of the meninges, the fluid and membranes surrounding the brain and spinal cord. Symptoms include headache, fever, and stiff neck. Most cases in the US are caused by viral infections, but bacteria, parasites, and fungi can also cause it. Some cases improve without treatment, while others can cause death and require emergency antibiotic treatment. Seeking immediate medical care is crucial for preventing serious complications.</p>

<h3>Market Scope</h3>

<table cellspacing="0" style="border-collapse:collapse">
	<tbody>
		<tr>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #4472c4; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			<p><strong>Metrics</strong></p>
			</td>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #8eaadb; border-right:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			<p><strong>Details</strong></p>
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			<p><strong>CAGR</strong></p>
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			<p>YY%</p>
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p><strong>Market Size Available for Years</strong></p>
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p>2022-2031</p>
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p><strong>Estimation Forecast Period</strong></p>
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p>2024-2031</p>
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p><strong>Revenue Units</strong></p>
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p>Value (US$ Mn)&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p><strong>Segments Covered</strong></p>
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p>Infection Type, Diagnosis Type, End User</p>
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p><strong>Regions Covered</strong></p>
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p>North America, Europe, Asia-Pacific, South America, and Middle East &amp; Africa</p>
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p><strong>Largest Region</strong></p>
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p>North America</p>
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p><strong>Fastest Growing Region</strong></p>
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p>Asia-Pacific</p>
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p><strong>Report Insights Covered</strong></p>
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p>Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter&rsquo;s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.</p>
			</td>
		</tr>
	</tbody>
</table>

<p><br />
&nbsp;</p>

<p><strong>For more details on this report</strong> <strong>&ndash; <a href="https://www.datamintelligence.com/download-sample/meningitis-diagnostic-testing-market" target="_blank">Request for Sample</a></strong></p>

<h3>&nbsp;</h3>

<h3>Market Dynamics: Drivers &amp; Restraints</h3>

<p><strong>Rise in the prevalence of meningitis</strong></p>

<p>The global meningitis diagnostic testing market is driven by rising global prevalence, demand for advanced diagnostics, point-of-care diagnostic services, and research and development investments for effective diagnosis and treatment, with the forecast period expected to be dominated by these factors.</p>

<p>For instance, according to a recent article published in NCBI,&nbsp; The incidence of meningitis worldwide is estimated to be 20 cases per 100,000 people; that is, about 1.2 million; the incidence and causes vary across geographic regions.</p>

<p><strong>Shortage of skilled professionals</strong></p>

<p>Accurate diagnosis of meningitis is crucial for timely and effective treatment, as the condition can progress rapidly and result in severe complications or death. However, several challenges related to the shortage of skilled healthcare professionals, particularly in rural and underdeveloped areas, can restrict the usage and effectiveness of diagnostic tests.&nbsp;</p>

<p>The lack of skilled professionals can lead to delays in diagnosis, which is critical for conditions like meningitis that progress rapidly. Delayed diagnosis can result in worse outcomes, including higher morbidity and mortality rates.</p>

<h3>Segment Analysis</h3>

<p>The global meningitis diagnostic testing market is segmented based on infection type, diagnosis type, end-user, and region.</p>

<p><strong>The PCR assay&nbsp; from the diagnosis type segment accounted for approximately 39.5% of the meningitis diagnostic testing&nbsp; market share</strong></p>

<p>The PCR assay from the diagnosis type segment accounted for approximately 39.5%. The PCR assay segment is expected to dominate during the forecast period owing to the factors like, the availability of RT-PCR platforms, which provide results in less than two hours, including multi-target and single-target detection tests. Technological advancements in PCR assays, which reduce turnaround times and promote precise diagnosis, are expected to further drive the segment&#39;s growth. The high sensitivity and precision of PCR tests are expected to further increase their adoption in meningitis testing.</p>

<p>For instance, in January 2024, QIAGEN announced that its QIAstat-Dx Meningitis/Encephalitis Panel, a qualitative multiplexed nucleic acid-based in vitro diagnostic test has received approval from the Health Sciences Authority Singapore (HSA).&nbsp; The QIAstat-Dx system is designed for use in laboratories and employs cost-efficient, single-use cartridges with all reagents on board and built-in sample processing. Utilizing multiplex real-time PCR, it detects and differentiates between multiple pathogens.3</p>

<h3>Geographical Analysis</h3>

<p><strong>North America is estimated to hold about 38.4% of the total market share throughout the forecast period</strong><strong> </strong></p>

<p>North America is estimated to hold about 38.4% of the total market share throughout the forecast period owing to factors due to strategic initiatives and the presence of leading players. High adoption of advanced diagnostic devices, easy access to test kits, increased awareness about early diagnosis, and an increase in diagnostic centres are expected to fuel region expansion. Government initiatives to promote infectious disease diagnosis offer lucrative growth opportunities in the future.</p>

<h3>Covid 19 Impact Analysis</h3>

<p>The COVID-19 pandemic significantly impacted the meningitis diagnostics testing market, as many people struggled to get routine immunizations due to the unavailability of primary care or self-isolation requirements. For instance, in February 2022, a study in Clinical Epidemiology and Global Health reported a meningitis outbreak in the Democratic Republic of Congo, causing strain on healthcare systems and a high case fatality rate of 50%.</p>

<h3>Market Segmentation</h3>

<p>By Infection Type</p>

<ul>
	<li>Bacterial</li>
	<li>Viral</li>
	<li>Fungal</li>
	<li>Others</li>
</ul>

<p>By Diagnosis Type</p>

<ul>
	<li>Latex Agglutination Tests</li>
	<li>PCR Assay</li>
	<li>Lateral Flow Assay</li>
	<li>ELISA Tests</li>
	<li>Culture Test</li>
	<li>Others</li>
</ul>

<p>By End-User</p>

<ul>
	<li>Hospitals</li>
	<li>Diagnostic Laboratories</li>
	<li>Clinics</li>
	<li>Others</li>
</ul>

<p>By Region</p>

<ul>
	<li>North America
	<ul>
		<li>U.S.</li>
		<li>Canada</li>
		<li>Mexico</li>
	</ul>
	</li>
	<li>Europe
	<ul>
		<li>Germany</li>
		<li>UK</li>
		<li>France</li>
		<li>Italy</li>
		<li>Spain</li>
		<li>Rest of Europe</li>
	</ul>
	</li>
	<li>South America
	<ul>
		<li>Brazil</li>
		<li>Argentina</li>
		<li>Rest of South America</li>
	</ul>
	</li>
	<li>Asia-Pacific
	<ul>
		<li>China</li>
		<li>India</li>
		<li>Japan</li>
		<li>South Korea</li>
		<li>Rest of Asia-Pacific</li>
	</ul>
	</li>
	<li>Middle East and Africa</li>
</ul>

<h3>Competitive Landscape</h3>

<p>The major global players in the market include Thermo Fisher Scientific Inc, Seegene Inc., BioFire Diagnostics LLC (BioM&eacute;rieux), Teco Diagnostics, ELITech Group, Transasia Bio-Medicals Ltd, Lepu Medical Technology Eurolyser Diagnostica, Gold Standard Diagnosticsa, Biorad laboratories Inc among others.</p>

<h3>Key Developments</h3>

<ul>
	<li>On October 26, 2023, LumiraDx unveiled a groundbreaking development in the field of medical diagnostics&mdash;the launch of its cutting-edge meningitis NxGen MenB &amp; Group C/G/Y Assay. This innovative molecular test represents a significant leap forward in point-of-care testing for meningitis B and other serogroups, promising a revolution in the timely diagnosis and treatment of this critical health condition.</li>
	<li>In July 2022, Abacus Diagnostica, a Uniogen company, launched a new rapid PCR test GenomEra assay kit (HSV-1/2, VZV + EV Assay Kit) in the European markets for the fast identification of viruses causing viral meningitis and encephalitis. This is a significant development in medical technology as it will allow for faster and more accurate diagnoses of these serious illnesses.</li>
</ul>

<h3>Why Purchase the Report?</h3>

<ul>
	<li>To visualize the global meningitis diagnostic testing market segmentation based on infection type, diagnosis type, end user, and region as well as understand key commercial assets and players.</li>
	<li>identify commercial opportunities by analyzing trends and co-development.&nbsp;</li>
	<li>excel data sheet with numerous data points of the meningitis diagnostic testing market level with all segments.</li>
	<li>PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.</li>
	<li>Product mapping available as Excel consisting of key products of all the major players.</li>
</ul>

<p><strong><em>The global meningitis diagnostic testing market report would provide approximately 64 tables, 61 figures, and 186 pages.</em></strong></p>

<h3>Target Audience 2024</h3>

<ul>
	<li>Manufacturers/ Buyers</li>
	<li>Industry Investors/Investment Bankers</li>
	<li>Research Professionals</li>
	<li>Emerging Companies</li>
</ul>


<ol>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Definition and Overview</h3>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Executive Summary</h3>

	<ol>
		<li>Snippet by Infection Type</li>
		<li>Snippet by Diagnosis Type</li>
		<li>Snippet by End User</li>
		<li>Snippet by Region</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Dynamics</h3>

	<ol>
		<li>Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Rise in&nbsp; the prevalence of meningitis</li>
				<li>Rise of technological advancement in testing kits</li>
			</ol>
			</li>
			<li>Restraints
			<ol>
				<li>Shortage of skilled professionals</li>
				<li>XX</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Industry Analysis&nbsp;</h3>

	<ol>
		<li>Porter&#39;s Five Force Analysis&nbsp;</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Patent Analysis</li>
		<li>PESTLE Analysis</li>
		<li>SWOT Analysis</li>
		<li>DMI Opinion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of COVID-19
		<ol>
			<li>Scenario Before COVID</li>
			<li>Scenario During COVID</li>
			<li>Scenario Post COVID</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid COVID-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By&nbsp; Infection Type</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Infection Type</li>
			<li>Market Attractiveness Index, By Infection Type</li>
		</ol>
		</li>
		<li>Bacterial *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Viral</h3>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Fungal</h3>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Others</h3>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Diagnosis Type</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Diagnosis Type</li>
			<li>Market Attractiveness Index, By Diagnosis Type</li>
		</ol>
		</li>
		<li>Latex Agglutination Tests*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">PCR Assay</h3>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Lateral Flow Assay</h3>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">ELISA Tests</h3>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Culture Test</h3>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Others</h3>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By End User</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Attractiveness Index, By End User</li>
		</ol>
		</li>
		<li>Hospitals*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Diagnostic Laboratories</h3>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Clinics</h3>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Others</h3>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Infection Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Diagnosis Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Infection Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Diagnosis Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>UK</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Infection Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Diagnosis Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia-Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Infection Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Diagnosis Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>South Korea</li>
				<li>Rest of Asia-Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Infection Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Diagnosis Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Competitive Landscape</h3>

	<ol>
		<li>Competitive Scenario</li>
		<li>Market Positioning/Share Analysis</li>
		<li>Mergers and Acquisitions Analysis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Company Profiles</h3>

	<ol>
		<li>Thermo Fisher Scientific, Inc*
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Financial Overview</li>
			<li>Key Developments</li>
		</ol>
		</li>
		<li>Seegene Inc</li>
		<li>BioFire Diagnostics LLC (BioM&eacute;rieux)&nbsp;&nbsp;&nbsp;</li>
		<li>Teco Diagnostics&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
		<li>ELITech Group&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
		<li>Transasia Bio-Medicals Ltd&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
		<li>Lepu Medical Technology&nbsp;&nbsp;</li>
		<li>Eurolyser Diagnostica&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
		<li>Gold Standard Diagnostics</li>
		<li>Bio-Rad Laboratories, Inc.&nbsp;<em>LIST NOT EXHAUSTIVE&nbsp;</em></li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Appendix</h3>

	<ol>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>


<p><strong>List of Tables</strong></p>

<p>Table 1 Global Meningitis Diagnostic Testing Market Value, By Infection Type, 2023, 2027 &amp; 2031 (US$ Million)</p>

<p>Table 2 Global Meningitis Diagnostic Testing Market Value, By Diagnosis Type, 2023, 2027 &amp; 2031 (US$ Million)</p>

<p>Table 3 Global Meningitis Diagnostic Testing Market Value, By End User, 2023, 2027 &amp; 2031 (US$ Million)</p>

<p>Table 4 Global Meningitis Diagnostic Testing Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)</p>

<p>Table 5 Global Meningitis Diagnostic Testing Market Value, By Infection Type, 2023, 2027 &amp; 2031 (US$ Million)</p>

<p>Table 6 Global Meningitis Diagnostic Testing Market Value, By Infection Type, 2022-2031 (US$ Million)</p>

<p>Table 7 Global Meningitis Diagnostic Testing Market Value, By Diagnosis Type, 2023, 2027 &amp; 2031 (US$ Million)</p>

<p>Table 8 Global Meningitis Diagnostic Testing Market Value, By Diagnosis Type, 2022-2031 (US$ Million)</p>

<p>Table 9 Global Meningitis Diagnostic Testing Market Value, By End User, 2023, 2027 &amp; 2031 (US$ Million)</p>

<p>Table 10 Global Meningitis Diagnostic Testing Market Value, By End User, 2022-2031 (US$ Million)</p>

<p>Table 11 Global Meningitis Diagnostic Testing Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)</p>

<p>Table 12 Global Meningitis Diagnostic Testing Market Value, By Region, 2022-2031 (US$ Million)</p>

<p>Table 13 North America Meningitis Diagnostic Testing Market Value, By Infection Type, 2022-2031 (US$ Million)</p>

<p>Table 14 North America Meningitis Diagnostic Testing Market Value, By Diagnosis Type, 2022-2031 (US$ Million)</p>

<p>Table 15 North America Meningitis Diagnostic Testing Market Value, By End User, 2022-2031 (US$ Million)</p>

<p>Table 16 North America Meningitis Diagnostic Testing Market Value, By Country, 2022-2031 (US$ Million)</p>

<p>Table 17 Asia-Pacific Meningitis Diagnostic Testing Market Value, By Infection Type, 2022-2031 (US$ Million)</p>

<p>Table 18 Asia-Pacific Meningitis Diagnostic Testing Market Value, By Diagnosis Type, 2022-2031 (US$ Million)</p>

<p>Table 19 Asia-Pacific Meningitis Diagnostic Testing Market Value, By End User, 2022-2031 (US$ Million)</p>

<p>Table 20 Asia-Pacific Meningitis Diagnostic Testing Market Value, By Country, 2022-2031 (US$ Million)</p>

<p>Table 21 Europe Meningitis Diagnostic Testing Market Value, By Infection Type, 2022-2031 (US$ Million)</p>

<p>Table 22 Europe Meningitis Diagnostic Testing Market Value, By Diagnosis Type, 2022-2031 (US$ Million)</p>

<p>Table 23 Europe Meningitis Diagnostic Testing Market Value, By End User, 2022-2031 (US$ Million)</p>

<p>Table 24 Europe Meningitis Diagnostic Testing Market Value, By Country, 2022-2031 (US$ Million)</p>

<p>Table 25 South America Meningitis Diagnostic Testing Market Value, By Infection Type, 2022-2031 (US$ Million)</p>

<p>Table 26 South America Meningitis Diagnostic Testing Market Value, By Diagnosis Type, 2022-2031 (US$ Million)</p>

<p>Table 27 South America Meningitis Diagnostic Testing Market Value, By End User, 2022-2031 (US$ Million)</p>

<p>Table 28 South America Meningitis Diagnostic Testing Market Value, By Country, 2022-2031 (US$ Million)</p>

<p>Table 29 Middle East and Africa Meningitis Diagnostic Testing Market Value, By Infection Type, 2022-2031 (US$ Million)</p>

<p>Table 30 Middle East and Africa Meningitis Diagnostic Testing Market Value, By Diagnosis Type, 2022-2031 (US$ Million)</p>

<p>Table 31 Middle East and Africa Meningitis Diagnostic Testing Market Value, By End User, 2022-2031 (US$ Million)</p>

<p>Table 32 Middle East and Africa Meningitis Diagnostic Testing Market Value, By Country, 2022-2031 (US$ Million)</p>

<p>Table 33 Thermo Fisher Scientific Inc: Overview</p>

<p>Table 34 Thermo Fisher Scientific Inc: Product Portfolio</p>

<p>Table 35 Thermo Fisher Scientific Inc: Key Developments</p>

<p>Table 36 Seegene Inc: Overview</p>

<p>Table 37 Seegene Inc: Product Portfolio</p>

<p>Table 38 Seegene Inc: Key Developments</p>

<p>Table 39 BioFire Diagnostics LLC (BioM&eacute;rieux): Overview</p>

<p>Table 40 BioFire Diagnostics LLC (BioM&eacute;rieux): Product Portfolio</p>

<p>Table 41 BioFire Diagnostics LLC (BioM&eacute;rieux): Key Developments</p>

<p>Table 42 Teco Diagnostics: Overview</p>

<p>Table 43 Teco Diagnostics: Product Portfolio</p>

<p>Table 44 Teco Diagnostics: Key Developments</p>

<p>Table 45 ELITech Group : Overview</p>

<p>Table 46 ELITech Group: Product Portfolio</p>

<p>Table 47 ELITech Group: Key Developments</p>

<p>Table 48 Transasia Bio-Medicals Ltd: Overview</p>

<p>Table 49 Transasia Bio-Medicals Ltd: Product Portfolio</p>

<p>Table 50 Transasia Bio-Medicals Ltd: Key Developments</p>

<p>Table 51 Lepu Medical Technology: Overview</p>

<p>Table 52 Lepu Medical Technology: Product Portfolio</p>

<p>Table 53 Lepu Medical Technology: Key Developments</p>

<p>Table 54 Eurolyser Diagnostica: Overview</p>

<p>Table 55 Eurolyser Diagnostica: Product Portfolio</p>

<p>Table 56 Eurolyser Diagnostica: Key Developments</p>

<p>Table 57 Gold Standard Diagnostics: Overview</p>

<p>Table 58 Gold Standard Diagnostics: Product Portfolio</p>

<p>Table 59 Gold Standard Diagnostics: Key Developments</p>

<p>Table 60 Bio-Rad Laboratories, Inc: Overview</p>

<p>Table 61 Bio-Rad Laboratories, Inc: Product Portfolio</p>

<p>Table 62 Bio-Rad Laboratories, Inc: Key Developments</p>

<p><strong>List of Figures</strong></p>

<p>Figure 1 Global Meningitis Diagnostic Testing Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 2 Global Meningitis Diagnostic Testing Market Share, By Infection Type, 2023 &amp; 2031 (%)</p>

<p>Figure 3 Global Meningitis Diagnostic Testing Market Share, By Diagnosis Type, 2023 &amp; 2031 (%)</p>

<p>Figure 4 Global Meningitis Diagnostic Testing Market Share, By End User, 2023 &amp; 2031 (%)</p>

<p>Figure 5 Global Meningitis Diagnostic Testing Market Share, By Region, 2023 &amp; 2031 (%)</p>

<p>Figure 6 Global Meningitis Diagnostic Testing Market Y-o-Y Growth, By Infection Type, 2023-2031 (%)</p>

<p>Figure 7 Bacterial Meningitis Diagnostic Testing Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 8 Viral Meningitis Diagnostic Testing Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 9 Fungal Meningitis Diagnostic Testing Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 10 Others Meningitis Diagnostic Testing Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 11 Global Meningitis Diagnostic Testing Market Y-o-Y Growth, By Diagnosis Type, 2023-2031 (%)</p>

<p>Figure 12 Latex Agglutination Tests Diagnosis Type in Global Meningitis Diagnostic Testing Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 13 PCR Assay Diagnosis Type in Global Meningitis Diagnostic Testing Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 14 Lateral Flow Assay Diagnosis Type in Global Meningitis Diagnostic Testing Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 15 ELISA Tests Diagnosis Type in Global Meningitis Diagnostic Testing Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 16 Culture Test Diagnosis Type in Global Meningitis Diagnostic Testing Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 17 Others Diagnosis Type in Global Meningitis Diagnostic Testing Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 18 Global Meningitis Diagnostic Testing Market Y-o-Y Growth, By End User, 2023-2031 (%)</p>

<p>Figure 19 Hospitals End User in Global Meningitis Diagnostic Testing Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 20 Diagnostic Laboratories End User in Global Meningitis Diagnostic Testing Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 21 Clinics End User in Global Meningitis Diagnostic Testing Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 22 Others End User in Global Meningitis Diagnostic Testing Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 23 Global Meningitis Diagnostic Testing Market Y-o-Y Growth, By Region, 2023-2031 (%)</p>

<p>Figure 24 North America Meningitis Diagnostic Testing Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 25 North America Meningitis Diagnostic Testing Market Share, By Infection Type, 2023 &amp; 2031 (%)</p>

<p>Figure 26 North America Meningitis Diagnostic Testing Market Share, By Diagnosis Type, 2023 &amp; 2031 (%)</p>

<p>Figure 27 North America Meningitis Diagnostic Testing Market Share, By End User, 2023 &amp; 2031 (%)</p>

<p>Figure 28 North America Meningitis Diagnostic Testing Market Share, By Country, 2023 &amp; 2031 (%)</p>

<p>Figure 29 Asia-Pacific Meningitis Diagnostic Testing Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 30 Asia-Pacific Meningitis Diagnostic Testing Market Share, By Infection Type, 2023 &amp; 2031 (%)</p>

<p>Figure 31 Asia-Pacific Meningitis Diagnostic Testing Market Share, By Diagnosis Type, 2023 &amp; 2031 (%)</p>

<p>Figure 32 Asia-Pacific Meningitis Diagnostic Testing Market Share, By End User, 2023 &amp; 2031 (%)</p>

<p>Figure 33 Asia-Pacific Meningitis Diagnostic Testing Market Share, By Country, 2023 &amp; 2031 (%)</p>

<p>Figure 34 Europe Meningitis Diagnostic Testing Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 35 Europe Meningitis Diagnostic Testing Market Share, By Infection Type, 2023 &amp; 2031 (%)</p>

<p>Figure 36 Europe Meningitis Diagnostic Testing Market Share, By Diagnosis Type, 2023 &amp; 2031 (%)</p>

<p>Figure 37 Europe Meningitis Diagnostic Testing Market Share, By End User, 2023 &amp; 2031 (%)</p>

<p>Figure 38 Europe Meningitis Diagnostic Testing Market Share, By Country, 2023 &amp; 2031 (%)</p>

<p>Figure 39 South America Meningitis Diagnostic Testing Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 40 South America Meningitis Diagnostic Testing Market Share, By Infection Type, 2023 &amp; 2031 (%)</p>

<p>Figure 41 South America Meningitis Diagnostic Testing Market Share, By Diagnosis Type, 2023 &amp; 2031 (%)</p>

<p>Figure 42 South America Meningitis Diagnostic Testing Market Share, By End User, 2023 &amp; 2031 (%)</p>

<p>Figure 43 South America Meningitis Diagnostic Testing Market Share, By Country, 2023 &amp; 2031 (%)</p>

<p>Figure 44 Middle East and Africa Meningitis Diagnostic Testing Market Value, 2022-2031 (US$ Million)</p>

<p>Figure 45 Middle East and Africa Meningitis Diagnostic Testing Market Share, By Infection Type, 2023 &amp; 2031 (%)</p>

<p>Figure 46 Middle East and Africa Meningitis Diagnostic Testing Market Share, By Diagnosis Type, 2023 &amp; 2031 (%)</p>

<p>Figure 47 Middle East and Africa Meningitis Diagnostic Testing Market Share, By End User, 2023 &amp; 2031 (%)</p>

<p>Figure 48 Thermo Fisher Scientific Inc: Financials</p>

<p>Figure 49 Seegene Inc: Financials</p>

<p>Figure 50 BioFire Diagnostics LLC (BioM&eacute;rieux): Financials</p>

<p>Figure 51 Teco Diagnostics: Financials</p>

<p>Figure 52 ELITech Group: Financials</p>

<p>Figure 53 Transasia Bio-Medicals Ltd: Financials</p>

<p>Figure 54 Lepu Medical Technology: Financials</p>

<p>Figure 55 Eurolyser Diagnostica: Financials</p>

<p>Figure 56 Gold Standard Diagnostics: Financials</p>

<p>Figure 57 Bio-Rad Laboratories, Inc: Financials</p>


Meningitis Diagnostic Testing Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Disposable Underpads Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 September 02

Starting from

Disposable Oxygen Masks Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2024 September 03

Starting from

Disposable Medical Gloves Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 May 25

Starting from